Intrinsic Value of S&P & Nasdaq Contact Us

NanoString Technologies, Inc. NSTG NASDAQ

NASDAQ Global Market • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
39/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$21.50
+20317.9%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

NanoString Technologies, Inc. (NSTG) .

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+20317.9%).
  • Analyst consensus target $21.50 (+20317.9% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 39/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
36/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — NSTG

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-3.44
Book Value / Share$0.00
Revenue / Share$2.74
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$21.50 (+20317.9%)

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2013 $-3.83 $31.4M $-29.28M -93.2%
2014 $-2.80 $47.59M $-50.04M -105.1%
2015 $-2.40 $62.67M $-45.58M -72.7%
2016 $-2.34 $86.49M $-47.09M -54.4%
2017 $-1.84 $114.91M $-43.56M -37.9%
2018 $-2.78 $106.73M $-77.4M -72.5%
2019 $-1.18 $125.57M $-40.7M -32.4%
2020 $-2.82 $117.32M $-110.08M -93.8%
2021 $-2.54 $145.09M $-115.25M -79.4%
2022 $-3.44 $127.26M $-159.54M -125.4%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message